
Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Fax+1 507-284-1803
Dr. Heath is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elisabeth Heath is a nationally and internationally recognized expert in genitourinary oncology, serving as the Chair of the Department of Oncology at the Mayo Clinic in Rochester, MN. She specializes in clinical and translational research, focusing on early-phase and genitourinary clinical trials and improving care for all patients. Her expertise covers a range of genitourinary cancers, including prostate, kidney, and bladder cancer.
In addition to her clinical work, Dr. Heath has led large-scale, multi-institutional, peer-reviewed research initiatives aimed at fostering collaboration across medical disciplines. Her goal is to integrate research and clinical practice, translating scientific discoveries into real-world treatments.
Dr. Heath is also committed to improving patient access to care and their experience during treatment. She emphasizes collaboration within multidisciplinary teams to achieve holistic, effective patient outcomes. Her leadership and innovative approaches have advanced the understanding and treatment of genitourinary cancers while shaping cancer care practices both nationally and internationally. Through her work, Dr. Heath continues to contribute significantly to the oncology community, with a focus on patient-centered care and driving innovation in cancer care.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1993 - 1996
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1993
Certifications & Licensure
MN State Medical License 2024 - 2027
MI State Medical License 2003 - 2025
MD State Medical License 1996 - 2004
VA State Medical License 1994 - 2004
American Board of Internal Medicine Medical Oncology
Clinical Trials
- 17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
- Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
Publications & Presentations
PubMed
- Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized ...Channing J Paller, Ken Freitas, Natalie Macario, Christina Tran, Kelly Faville
Contemporary Clinical Trials Communications. 2026-10-01 - 1 citationsCase series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant.Mayuko Kanayama, Emeline Colomba, Yusra Shao, Sarah M Nielsen, Edward D Esplin
Prostate Cancer and Prostatic Diseases. 2026-09-01 - Interconnectedness of Factors Affecting Patient Willingness to Discuss Prostate Cancer Clinical Trials With Physicians.Janaka S S Liyanage, Vy Ong, Lauren M Hamel, Susan Eggly, Michael A Carducci
JCO Oncology Practice. 2026-08-24
Journal Articles
- Willingness to Discuss Clinical Trials Among Black vs White Men with Prostate CancerElisabeth Heath, MD, JAMA Oncology
Authored Content
- Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer - Elisabeth HeathNovember 2023
Press Mentions
Hope in the Fight: Dr. Elisabeth Heath and the Power of Cancer ResearchJune 16th, 2025
Local Doctors Weigh in on AI in MedicineOctober 8th, 2024
Intervention to Improve Patient-Physician Communication May Improve Black Patient Participation in Clinical Trials, Study Led by Karmanos ResearcherFebruary 27th, 2023
Grant Support
- Michigan Prostate SPOREUNIVERSITY OF MICHIGAN AT ANN ARBOR2014–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









